MARSHALL WACE, LLP Vertex Pharmaceuticals Incorporated Transaction History

MARSHALL WACE, LLP portfolio value:

$79.29M
portfolio value

MARSHALL WACE, LLP quarter portfolio value change:

+2.75%
quarter

Vertex Pharmaceuticals Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -29.99% -117.3K shares -30.93M $289.54 273.85K
Q2 2022 share Increase 0.00% 391.15K shares 110.22M $281.79 391.15K
Q1 2022 share Decrease -100.00% -150K shares -32.94M $260.97 0
Q4 2021 share Decrease -73.05% -406.67K shares -68.03M $222.45 150K
Q3 2021 share Increase +1.04% 5.71K shares -10.11M $181.39 556.67K
Q2 2021 share Increase +195.06% 364.23K shares 70.96M $201.63 550.95K
Q1 2021 share Decrease -6.44% -12.85K shares -7.04M $214.89 186.72K
Q4 2020 share Increase +381.30% 158.11K shares 35.88M $236.34 199.58K
Q3 2020 share Increase +797.19% 36.84K shares 9.94M $272.12 41.46K
Q2 2020 share Increase +622.19% 3.98K shares 1.19M $290.31 4.62K
Q1 2020 share Decrease -98.29% -36.88K shares -8.06M $237.95 640
Q4 2019 share Decrease -48.99% -36.03K shares -4.24M $218.95 37.52K
Q3 2019 share Decrease -20.29% -18.72K shares -4.46M $169.42 73.55K
Q2 2019 share Increase +48.29% 30.05K shares 5.47M $183.38 92.28K
Q1 2019 share Increase +1.09% 672 shares 1.24M $183.95 62.23K
Q4 2018 share Decrease -66.69% -123.25K shares -25.42M $165.71 61.56K
Q3 2018 share Decrease -50.91% -191.67K shares -28.36M $192.74 184.81K
Q2 2018 share Increase +1027.50% 343.09K shares 58.54M $169.96 376.48K
Q1 2018 share Decrease -69.83% -77.27K shares -11.14M $162.98 33.39K
Q4 2017 share Increase +413.12% 89.09K shares 13.30M $149.86 110.66K
Q3 2017 share Decrease -55.83% -27.26K shares -3.02M $152.04 21.56K
Q2 2017 share Increase 0.00% 48.83K shares 6.29M $128.87 48.83K
Q1 2016 share Decrease -100.00% -241.82K shares -30.42M $79.49 0